UNITENSEN Drug Patent Profile
✉ Email this page to a colleague
When do Unitensen patents expire, and when can generic versions of Unitensen launch?
Unitensen is a drug marketed by Medpointe Pharm Hlc and is included in two NDAs.
The generic ingredient in UNITENSEN is cryptenamine tannates. Additional details are available on the cryptenamine tannates profile page.
Summary for UNITENSEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 203 |
Patent Applications: | 4,011 |
DailyMed Link: | UNITENSEN at DailyMed |
US Patents and Regulatory Information for UNITENSEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | UNITENSEN | cryptenamine acetates | INJECTABLE;INJECTION | 008814-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | UNITENSEN | cryptenamine tannates | TABLET;ORAL | 009217-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |